🇺🇸 FDA

Intelligence Platform

Patents

Browse 373 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8796254

Methods for using carboxamide, sulfonamide and amine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8791136

Substituted pyridine, pyridazine, pyrazine and pyrimidine compounds and methods for using

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785449

Carboxamide compounds and methods for using the same

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8785437

Prodrugs of 2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 22 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8771648

(Trimethoxyphenylamino) pyrimidinyl formulations

Rigel Pharmaceuticals, Inc. · Granted Tue Jul 08 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 03 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8748597

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 10 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 05 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8741898

Polycyclic heteroaryl substituted triazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 03 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 29 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8735418

Pyrimidine-2-amine compounds and their use as inhibitors of JAK kinases

Rigel Pharmaceuticals, Inc. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8735400

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue May 27 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 22 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8729087

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue May 20 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 15 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8710223

Protein kinase C inhibitors and uses thereof

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 29 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 24 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8697727

N-substituted-heterocycloalkyloxybenzamide compounds and methods of use

Rigel Pharmaceuticals, Inc. · Granted Tue Apr 15 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8658669

Bridged bicyclic heteroaryl substituted triazoles useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 25 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 20 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8652492

Wet granulation using a water sequestering agent

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 18 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8642593

2,4-pyrimidinediamine compounds and prodrugs and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Feb 04 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8637038

Methods for inhibiting allograft rejection

Rigel Pharmaceuticals, Inc. · Granted Tue Jan 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618331

Polycyclic heteroaryl substituted triazoles useful as axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8618095

2, 4-pyrimidinediamine compounds and prodrugs thereof and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 31 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8609650

Bridged bicyclic aryl and bridged bicyclic heteroaryl substituted triazoles useful as Axl

Rigel Pharmaceuticals, Inc. · Granted Tue Dec 17 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8575165

Methods for treating inflammatory disorders using 2,4-pyrimidinediamine compounds

Rigel Pharmaceuticals, Inc. · Granted Tue Nov 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8569340

AMPK-activating piperidinyloxypyiridine carboxamide and sulfonamide compounds and methods

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 29 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563716

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563569

Compositions and methods for inhibition of the JAK pathway

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 8563559

Pinane-substituted pyrimidinediamine derivatives useful as Axl inhibitors

Rigel Pharmaceuticals, Inc. · Granted Tue Oct 22 2013 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted